Benoxinate: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Benoxinate. Educational only — not medical advice.
Labeled uses
Fluorescein Sodium and Benoxinate Hydrochloride Ophthalmic Solution, 0.3%/0.4% is indicated for ophthalmic procedures in adult and pediatric patients requiring a disclosing agent in combination with a topical ophthalmic anesthetic agent.
Source: FDA labeling via NIH DailyMed (set 1797c5ef…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.